Progress has been achieved in curative treatments for Hepatitis C virus (HCV), however efficient cures are needed for Hepatitis B virus (HBV) and Human immunodeficiency virus (HIV). Since these pathogens have limited species tropism, infecting humans but not mice, understanding the infectious life cycle, pathological mechanisms, and testing novel drug strategies or vaccine candidates has been problematic. To overcome these limitations, we have been developing “humanized” murine models that harbor human cells, rendering mice susceptible to these infections to study immune responses and virus-host crosstalk.
Click to view graph
		
			
			Connections
		
	Members
Former Members
2000
				        2000
				        Name
				        Position
			      	2019
				        	2023
				        	Anna Thaller
				        	PhD student
				        2019
				        	2022
				        	Priyanka Fernandes
				        	Post-doc
				        2015
				        	2022
				        	Oriane Fiquet
				        	Assistant Engineer
				        2018
				        	2021
				        	Giulia Girelli-Zubani
				        	Post-doc
				        2014
				        	2019
				        	Guillemette Masse-Ranson
				        	Post-doc
				        2017
				        	2019
				        	Maud Boussand
				        	Assistant Engineer
				        2011
				        	2014
				        	Mathilde Dusséaux
				        	Post-doc
				        2009
				        	2015
				        	Sylvie Darche
				        	Research Engineer
				        Projects
Transversal Project
Fundings
Publications
Download- 
							
	2023A human immune system (HIS) mouse model that dissociates roles for mouse and human FcR+ cells during antibody-mediated immune responses., Eur J Immunol 2023 Aug; (): e2350454.
- 
							
	2021Animal Models for Hepatitis B: Does the Supply Meet the Demand?, Gastroenterology 2021 April;160(5):1437-42 .
- 
							
	2020Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers., J. Exp. Med. 2020 ; 217(10): .
- 
							
	2020In-vitro and in-vivo models for hepatitis B cure research., Curr Opin HIV AIDS 2020 May; 15(3): 173-179.
- 
							
	2020Novel Hepatitis B Virus Capsid Assembly Modulator Induces Potent Antiviral Responses In Vitro and in Humanized Mice., Antimicrob Agents Chemother 2020 01; 64(2): .
- 
							
	2019Accelerated thymopoiesis and improved T-cell responses in HLA-A2/-DR2 transgenic BRGS-based human immune system mice., Eur J Immunol 2019 06; 49(6): 954-965.
- 
							
	2018Who Defends the Stem Cell’s Citadel?, Cell Stem Cell 2018 Mar;22(3):287-289.
- 
							
	2017Regulatory T cells control toxicity in a humanized model of IL-2 therapy, Nat Commun 2017 11;8(1):1762.
- 
							
	2017Modeling hepatitis virus infections and treatment strategies in humanized mice, Curr Opin Virol 2017 Aug;25:119-125.
- 
							
	2017Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver., Gastroenterology 2017 12; 153(6): 1647-1661.e9.
- 
							
								+View full list of publications
Contact
Phone:
Email: helene.strick-marchand@pasteur.fr
Address
25-28 Rue du Docteur Roux
75015, Paris
France


 
															
 
			
		 
			
		 
			
		 
							
